Mays upset with ex-owner of Pathway Productions
Pathway Productions, purveyors of some of the highest-profile documentaries to come out of the Indianapolis area in the last
decade, is on the brink of extinction.
Pathway Productions, purveyors of some of the highest-profile documentaries to come out of the Indianapolis area in the last
decade, is on the brink of extinction.
Lawyers holding doctorates in biotech, biology, chemistry and computer sciences are in high demand by firms with strong intellectual
property practices.
United Way of Central Indiana CEO Ellen Annala is thankful for the $38.8 million in pledges to its annual campaign, although it didn’t quite reach its $40 million fund-raising goal.
The trio of attorneys who practice in the local office of Barnes & Thornburg LLP’s life sciences group is a self-deprecating, peculiar bunch. Not only are the three the punch line of an occasional lawyer joke, but they’re also the target of lighthearted ribbing about their scholarly credentials. “We’re the geeky group,” patent attorney Kevin […]
After two mega-mergers last week among pharma companies, the buzz grew deafening with speculation about future mergers, including the possibility of Eli Lilly and Co. linking up with Bristol-Myers Squibb Co. Indianapolis-based Lilly has steadfastly said it’s not interested in big mergers. But even if Lilly wanted to merge, does it have the capital to […]
Eli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made
from cells.
Locally based Dow AgroSciences, one of Indianapolis’ top employers, may not be going on the sale block after all.
Eli Lilly and Co. won U.S. approval for its drug Symbyax as a medicine for treatment-resistant depression, the company announced today. The U.S. Food and Drug Administration OK’d Symbyax as the first drug for the acute treatment of treatment-resistant depression. So-called TRD is depression that has not improved when treated by two other antidepressants. Symbyax […]
Eli Lilly and Co. won U.S. approval for its drug Symbyax as a medicine for treatment-resistant depression, the company announced today. The U.S. Food and Drug Administration OK’d Symbyax as the first drug for the acute treatment of treatment-resistant depression. So-called TRD is depression that has not improved when treated by two other antidepressants. Symbyax […]
Lilly Endowment Inc. will give $20 million to an affiliate of the Community Foundation of Greater Fort Wayne to develop workforce-training initiatives, the Indianapolis-based endowment announced today. The aim of the program, dubbed Talent Opportunity Success, is to better prepare northeast Indiana’s workforce for job opportunities in the areas of science, technology, engineering and mathematics. […]
A new group funded by pharmaceutical and medical products companies – and co-chaired by former Indianapolis Mayor Bart Peterson and Indiana Pacers President Jim Morris – will publicly launch itself today with a press event at the Indiana Statehouse. Hoosiers Work for Health is a not-for-profit that wants to hold educational forums about health care […]
The hiring of minority- and women-owned businesses to work on the $275 million Indiana Convention Center expansion is far ahead of state requirements and has surpassed rates that were registered for the $715 million Lucas Oil Stadium project. More than 28 percent of the $215 million in bids awarded so far has gone to minority- […]
At a time when many professional sports teams are seeing their revenue drop in the wake of a rocky economy, the Indianapolis Indians are driving in runs. The AAA minor-league baseball team’s sponsorship revenue this year has already nearly matched what the franchise brought in all of last year, and could be on its way […]
Indianapolis-based Eli Lilly and Co.’s experimental drug for schizophrenia did not prove in its latest test that it works better than existing medication, the company announced today. The drug showed promise in an early study two years ago, but Lilly said the drug performed inconclusively in a Phase II clinical trial. The drug maker said […]
My wife, Becky, is alive today because of Lilly and its trial drug Enzastaurin, a great surgeon, and a terrific team of local doctors.
Despite the bad economy, the Indianapolis Indians’ franchise could make a record amount of money in 2009.
The hiring of minority- and women-owned
businesses to work on the $275 million Indiana Convention Center expansion is far ahead of state requirements and has surpassed
rates that were registered for the $715 million Lucas Oil Stadium project.
CEO John Lechleiter is ruling out Eli Lilly and Co.’s participation in the drug industry’s recent round of mega-mergers, the Financial Times reported today. At the same time, the Indianapolis-based company isn’t stepping back from collaborations. It announced its most recent today: a heart-drug development deal with Mumbai, India-based Cadila Healthcare Ltd. Lechleiter specifically ruled […]
CEO John Lechleiter is ruling out Eli Lilly and Co.’s participation in the drug industry’s recent round of mega-mergers, the Financial Times reported today. At the same time, the Indianapolis-based company isn’t stepping back from collaborations. It announced its most recent today: a heart-drug development deal with Mumbai, India-based Cadila Healthcare Ltd. Lechleiter specifically ruled […]
Eli Lilly and Co. and two drug-development partners said a once-weekly version of the diabetes medicine Byetta proved better at lowering patients’ blood sugar than two competing drugs. Lilly is working with California-based Amylin Pharmaceuticals Inc. and Massachusetts-based Alkermes Inc. to bring once-weekly Byetta, also called exanatide, to market by 2010. The drug is currently […]